Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04874207
Title Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib (RePERSO)
Acronym RePERSO
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Rennes University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Brest NOT_YET_RECRUITING Brest France Details
CHU Caen RECRUITING Caen France Details
AP-HP Henri Mondor RECRUITING Créteil France Details
Institut Daniel Hollard, Groupe Hospitalier Mutualiste de Grenoble RECRUITING Grenoble France Details
CHU Nantes RECRUITING Nantes France Details
AP-HP La Pitié-Salpétrière NOT_YET_RECRUITING Paris France Details
AP-HP St Antoine RECRUITING Paris France Details
CHU Poitiers RECRUITING Poitiers France Details
Centre Eugène Marquis RECRUITING Rennes France Details
CHU Rennes RECRUITING Rennes France Details
CHU Rouen RECRUITING Rouen France Details
CHU Tours RECRUITING Tours France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field